These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 28441487)

  • 1. The Isomeric Preference of an Atypical Dopamine Transporter Inhibitor Contributes to Its Selection of the Transporter Conformation.
    Abramyan AM; Stolzenberg S; Li Z; Loland CJ; Noé F; Shi L
    ACS Chem Neurosci; 2017 Aug; 8(8):1735-1746. PubMed ID: 28441487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular dynamics of conformation-specific dopamine transporter-inhibitor complexes.
    Jean B; Surratt CK; Madura JD
    J Mol Graph Model; 2017 Sep; 76():143-151. PubMed ID: 28734204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The atypical stimulant and nootropic modafinil interacts with the dopamine transporter in a different manner than classical cocaine-like inhibitors.
    Schmitt KC; Reith ME
    PLoS One; 2011; 6(10):e25790. PubMed ID: 22043293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopamine Transporter Dynamics of
    Hong WC; Wasko MJ; Wilkinson DS; Hiranita T; Li L; Hayashi S; Snell DB; Madura JD; Surratt CK; Katz JL
    J Pharmacol Exp Ther; 2018 Sep; 366(3):527-540. PubMed ID: 29945932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of cocaine-, benztropine-, and GBR12909-like compounds with wild-type and mutant human dopamine transporters: molecular features that differentially determine antagonist-binding properties.
    Schmitt KC; Zhen J; Kharkar P; Mishra M; Chen N; Dutta AK; Reith ME
    J Neurochem; 2008 Nov; 107(4):928-40. PubMed ID: 18786172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological characterization of a dopamine transporter ligand that functions as a cocaine antagonist.
    Desai RI; Grandy DK; Lupica CR; Katz JL
    J Pharmacol Exp Ther; 2014 Jan; 348(1):106-15. PubMed ID: 24194528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutation of Trp84 and Asp313 of the dopamine transporter reveals similar mode of binding interaction for GBR12909 and benztropine as opposed to cocaine.
    Chen N; Zhen J; Reith ME
    J Neurochem; 2004 May; 89(4):853-64. PubMed ID: 15140185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atypical dopamine transporter inhibitors R-modafinil and JHW 007 differentially affect D2 autoreceptor neurotransmission and the firing rate of midbrain dopamine neurons.
    Avelar AJ; Cao J; Newman AH; Beckstead MJ
    Neuropharmacology; 2017 Sep; 123():410-419. PubMed ID: 28625719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recognition of benztropine by the dopamine transporter (DAT) differs from that of the classical dopamine uptake inhibitors cocaine, methylphenidate, and mazindol as a function of a DAT transmembrane 1 aspartic acid residue.
    Ukairo OT; Bondi CD; Newman AH; Kulkarni SS; Kozikowski AP; Pan S; Surratt CK
    J Pharmacol Exp Ther; 2005 Aug; 314(2):575-83. PubMed ID: 15879005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behavioral, biological, and chemical perspectives on atypical agents targeting the dopamine transporter.
    Reith ME; Blough BE; Hong WC; Jones KT; Schmitt KC; Baumann MH; Partilla JS; Rothman RB; Katz JL
    Drug Alcohol Depend; 2015 Feb; 147():1-19. PubMed ID: 25548026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting of dopamine transporter to filopodia requires an outward-facing conformation of the transporter.
    Ma S; Cheng MH; Guthrie DA; Newman AH; Bahar I; Sorkin A
    Sci Rep; 2017 Jul; 7(1):5399. PubMed ID: 28710426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The binding sites for benztropines and dopamine in the dopamine transporter overlap.
    Bisgaard H; Larsen MA; Mazier S; Beuming T; Newman AH; Weinstein H; Shi L; Loland CJ; Gether U
    Neuropharmacology; 2011 Jan; 60(1):182-90. PubMed ID: 20816875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a dopamine transporter ligand that blocks the stimulant effects of cocaine.
    Desai RI; Kopajtic TA; Koffarnus M; Newman AH; Katz JL
    J Neurosci; 2005 Feb; 25(8):1889-93. PubMed ID: 15728828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gain of function mutants reveal sites important for the interaction of the atypical inhibitors benztropine and bupropion with monoamine transporters.
    Mortensen OV; Amara SG
    J Neurochem; 2006 Sep; 98(5):1531-40. PubMed ID: 16923164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. σ Receptor Effects of N-Substituted Benztropine Analogs: Implications for Antagonism of Cocaine Self-Administration.
    Hiranita T; Hong WC; Kopajtic T; Katz JL
    J Pharmacol Exp Ther; 2017 Jul; 362(1):2-13. PubMed ID: 28442581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Applicability of the dopamine and rate hypotheses in explaining the differences in behavioral pharmacology of the chloro-benztropine analogs: studies conducted using intracerebral microdialysis and population pharmacodynamic modeling.
    Othman AA; Newman AH; Eddington ND
    J Pharmacol Exp Ther; 2007 Aug; 322(2):760-9. PubMed ID: 17519385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel C-1 substituted cocaine analogs unlike cocaine or benztropine.
    Reith ME; Ali S; Hashim A; Sheikh IS; Theddu N; Gaddiraju NV; Mehrotra S; Schmitt KC; Murray TF; Sershen H; Unterwald EM; Davis FA
    J Pharmacol Exp Ther; 2012 Nov; 343(2):413-25. PubMed ID: 22895898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2-Substituted 3β-Aryltropane Cocaine Analogs Produce Atypical Effects without Inducing Inward-Facing Dopamine Transporter Conformations.
    Hong WC; Kopajtic TA; Xu L; Lomenzo SA; Jean B; Madura JD; Surratt CK; Trudell ML; Katz JL
    J Pharmacol Exp Ther; 2016 Mar; 356(3):624-34. PubMed ID: 26769919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between conformational changes in the dopamine transporter and cocaine-like subjective effects of uptake inhibitors.
    Loland CJ; Desai RI; Zou MF; Cao J; Grundt P; Gerstbrein K; Sitte HH; Newman AH; Katz JL; Gether U
    Mol Pharmacol; 2008 Mar; 73(3):813-23. PubMed ID: 17978168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative structure-activity relationships of benztropine analogues at the dopamine transporter and histamine H(1) receptors.
    Kulkarni SS; Kopajtic TA; Katz JL; Newman AH
    Bioorg Med Chem; 2006 Jun; 14(11):3625-34. PubMed ID: 16460947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.